New Zealand markets closed
  • NZX 50

    -220.33 (-1.93%)

    +0.0066 (+1.18%)

    +0.0049 (+0.83%)

    +19.80 (+0.30%)
  • ASX 200

    +18.90 (+0.29%)
  • OIL

    +0.95 (+1.24%)
  • GOLD

    +9.10 (+0.56%)

    -57.13 (-0.51%)
  • FTSE

    +2.35 (+0.03%)
  • Dow Jones

    -329.60 (-1.11%)
  • DAX

    -56.27 (-0.46%)
  • Hang Seng

    -128.68 (-0.72%)
  • NIKKEI 225

    +117.08 (+0.44%)

    +0.8600 (+1.05%)

Endovascular Aneurysm Repair Emerging as Frontrunner with Over Half Revenue Share of Vascular Grafts, Finds Fact.MR

·6-min read

Increasing Expenditure by Government Organizations on Healthcare Infrastructure and Strategic Mergers of Significant In Emerging Economies Will Market Growth over the Years to Come

Seoul, South Korea, Aug. 18, 2022 (GLOBE NEWSWIRE) -- According to a new report by Fact.MR, a market research and competitive intelligence provider, the global vascular grafts market is expected to reach a valuation of US$ 4.5 billion by 2026.

Vascular disorders are the cause of a substantial death rate worldwide, which has accelerated endovascular surgery advancements. Healthcare professionals are paying close attention to the development of long-term revascularization treatments that are efficient. In the market for vascular grafts, both synthetic and autologous grafts have become popular.

Additionally, increasing government standards to adopt high-quality patient care will encourage a big patient pool to seek treatment in hospitals, supporting industry growth. Market demand for vascular grafts will also be fueled by an increasing disease load and rising healthcare expenditures.

For Critical Insights on Vascular Grafts Market, Request a Sample Report

Market growth is anticipated to be driven by factors such as increasing prevalence of renal failure, arterial hardening, and technological advancements in the creation of devices to treat peripheral artery disease.

Vascular grafts market growth is also being influenced by rising consumer awareness of cutting-edge medical facilities and the availability of several surgical treatments. A kidney transplant is used to replace a kidney in the treatment of renal failure. Vascular grafts are used in kidney transplantation to repair the renal vasculature.

Which End User Will Emerge as Key Market Contributor?

“Wide Availability of Advanced Treatments Makes Hospitals Most Attractive”

On the basis of the end user, the market is segmented into hospitals and ambulatory surgical centers. Hospitals are projected to represent a significant share of the global vascular grafts market during the assessment period. Vascular grafts are typically used at hospitals since these facilities are eligible for government funding to cover the high cost of the equipment and services needed during an operation.

Due to heart examinations are frequently conducted in hospitals, medical technology and healthcare corporations are prioritizing these facilities as their top distribution locations for vascular grafts.

The most popular option and ideal location for vascular access operations, from dialysis to cardiovascular, are hospitals. The demand for vascular grafts in hospitals will be fueled by a wide range of possible treatments and the use of innovative technology that reduces post-operative problems.

To learn more about Vascular Grafts Market, you can get in touch with our Analyst at

Key Segments Covered in the Vascular Grafts Industry Survey

  • By Treatment :

    • Endovascular Aneurysm Repair (EVAR)

    • Peripheral Vascular Repair

    • Hemodialysis Access

  • By Raw Material :

    • Polyester

    • ePTFE

    • Polyurethane

    • Biosynthetic

  • By End User :

    • Hospitals

    • Ambulatory Surgical Centers

  • By Region :

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

Winning Strategy

Companies are engaged in researching tissue-engineered vascular grafts. With the primary objective of enhancing patient comfort, several market players have adopted various strategic activities such as alliances and the creation of innovative solutions. It is anticipated that this will maintain the industry dynamics and competitiveness.

For instance,

  • In 2021, Terumo Aortic obtained clearance for the Tero abdominal aortic stent grafts. Abdominal aortic aneurysms will benefit from the use of this Japanese equipment in treatment procedures.

Get Customization on Vascular Grafts Market Report for Specific Research Solutions

Key players in the Vascular Grafts Market

  • Endologix Inc.

  • OrbusNeich

  • Cook Medical

  • Cryolife

  • Getinge Group

  • LeMaitre Vascular Inc

  • Medtronic PLC

  • Terumo Medical Corporation

Key Takeaways from Vascular Grafts Market Study

  • Sales of vascular grafts predicted to rise at CAGR of 6.5% from 2022 to 2026.

  • Market in Japan anticipated to increase at CAGR of 5.5% over forecast period.

  • Peripheral vascular repair segment expected to rise at CAGR of 8.1%.

  • Market in Germany projected to increase at CAGR of 6.7% through 2026.

Explore Fact.MR's Coverage on the Healthcare Domain-

Drug Discovery Services Market- The drug discovery services market is forecasted to reach US$ 50 Billion by 2032, up from US$ 19 Billion in 2022, at a CAGR of 10.1%. A Y-o-Y growth rate of nearly 12% is expected for the market in 2022. As of 2021, the market was valued at US$ 17 Billion.

Patient Engagement Solutions Market- The global patient engagement solutions market, the market is gaining traction steadily, rising at an 8.6% CAGR through 2032, exceeding a valuation of around US$ 29 Billion by 2022. As of the end of 2032, the market is expected to reach US$ 66.4 Billion.

Emergency Medical Service Products Market- The worldwide emergency medical service products market is expected to increase at a CAGR of 6.3% and reach a market valuation of US$ 50 Billion by 2032. In 2021, the emergency medical service products market was worth US$ 25 Billion, and is expected to grow at a Y-o-Y expansion rate of 8% in 2022, reaching US$ 27 Billion.

Lab Automation Market- Demand for lab automation services experienced a Y-o-Y expansion rate of over 11% in 2022 compared to 2021, rising from US$ 1.8 Billion to US$ 2 Billion. Going forward, the market is poised to flourish at a 7% value CAGR from 2022-2032, reaching a valuation of nearly US$ 4 Billion.

Heart Attack Diagnostics Market- The heart attack diagnostics market is predicted to grow at a moderate CAGR of 7.1% during the forecast period of 2022 to 2032. The global heart attack diagnostics market is estimated to reach a value of nearly US$ 22.2 Billion by 2032 by growing from US$ 10.4 Billion in 2021.

Facial Implants Market- The global facial implant market was valued at US$ 2.7 Billion in 2022, and is expected to rise at a 7.7% value CAGR, likely to reach US$ 5.6 Billion by the end of the 2022-2032 forecast period.

Smart Implants Market- The global smart implants market is estimated at US$ 3.9 billion in 2022, and is forecast to surpass a market value of US$ 22.2 billion by 2032. Smart implants are expected to contribute significantly to the global implants market, with demand surging at a CAGR of 19% from 2022 to 2032.

Animal Model Market- The animal model market is expected to be worth US$ 1.7 Billion in 2022, rising to US$ 2.9 Billion by 2032, documenting a CAGR of 5.5% from 2022 to 2032.

Nerve Monitoring Devices Market- The global nerve monitoring devices market was valued at US$ 1.3 Billion in 2021, and is projected to register a Y-o-Y increase of 5.6% in 2022 to be valued at US$ 1.4 Billion.

Biotechnology Instruments Market- The global biotechnology Instrument market is likely to be valued at US$ 53.3 Billion in FY 2022, up from US$ 46.4 Billion in 2021. During the past year, the industry registered a Y-o-Y increase worth 14.9%.

About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Mahendra Singh
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
Tel: +1 (628) 251-1583
Follow Us: LinkedIn | Twitter